Vlad Coric

CNS pipeline · person

Vlad Coric, MD

Co-founder, Chairman and CEO of Biohaven, with more than 20 years of drug discovery and clinical development experience; an Associate Clinical Professor of Psychiatry at Yale School of Medicine who led the company from startup through its $13B acquisition by Pfizer and the spin-out of the new Biohaven Ltd.

  • 1 company

Courtesy Biohaven

Current roles

Appears with

People sharing a company with Vlad.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.